Results 221 to 230 of about 177,468 (356)

Antigen-specific human T-cell clones: development of clones requiring HLA-DR-compatible presenting cells for stimulation in presence of antigen. [PDF]

, 1981
Benjamin Sredni, D J Volkman, R H Schwartz, Anthony S. Fauci   +3 more
openalex   +1 more source

Isolation and identification of a cDNA clone corresponding to an HLA-DR antigen beta chain. [PDF]

, 1982
Klas G. Wiman, Dan Larhammar, Lena Claesson, Kenth Gustafsson, L. Schenning, P. Bill, Jan Böhme, Maurizio Denaro, B Dobberstein, Ulf Hammerling, Sune Kvist, B Servenius, Johan Sundelin, P A Peterson, Lars Rask   +14 more
openalex   +1 more source

Vaccine-induced donor-specific HLA antibodies: a case report highlighting sensitization risks in renal transplant waitlisted patients. [PDF]

Front Immunol
Kakodkar P, Shekari N, Mainra R, Webster D, Pearce T, Wu F, Mostafa A.   +6 more
europepmc   +1 more source

Analyses of HLA antigens, especially HLA-A and -B interlocus antigen, on platelets with monoclonal antibodies and elisa assay.

, 1987
Yoshisuke Nose, Nobuo Araki, Hiroji Yamahira, Junya Shimizu, Kaoru Sato, Takako Nakatsuji, Kimiyoshi Tsuji, Kazuo Ōno   +7 more
openalex   +2 more sources

Human T cell surface antigens bearing a structural relationship to HLA antigens. [PDF]

, 1981
T Cotner, Hiroshi Mashimo, Patrick C. Kung, G Goldstein, Jack L. Strominger   +4 more
openalex   +1 more source

Delineation of monocytic and early‐stage myeloid‐derived suppressor cells in the peripheral blood of patients with hepatocarcinoma

International Journal of Cancer, EarlyView.
What's new? In hepatocellular carcinoma, expanded myeloid‐derived suppressor cells (MDSC) relate to aggressiveness and poor prognosis. A global analysis of the different MDSC subsets in hepatocellular carcinoma is, however, missing. In this study, all three subsets of M‐MDSC, PMN‐MDSC, and eMDSC, together with arginase 1 activity, were significantly ...
Marta Chivite‐Lacaba, Iago Justo, Alberto Utrero‐Rico, Oscar Caso, Cecilia González‐Cuadrado, Manuel J. Del Rey, Rocio Laguna‐Goya, Javier Arroyo‐Ródenas, Ángel Alfocea‐Molina, Carlota C. Ruigómez‐Martín, Manuel Serrano, Lorena Pascual‐Palacios, María Esther Mancebo, Estela Paz‐Artal   +13 more
wiley   +1 more source

Identification of potential antigenic peptides of Brucella through proteome and peptidome

Veterinary Medicine and Science, Volume 9, Issue 1, Page 523-534, January 2023., 2023
Based on proteomics and peptidomics, we identified 35 peptides from the Brucella proteome, which have the ability to bind MHC molecules and have the potential to be used in vaccine design. In addition, we also found four Brucella proteins containing the identified MHC‐I and MHC‐II binding peptides, which may be good candidate targets for designing ...
Meijuan Pei, Ao Dong, Xueping Ma, Shulei Li, Yan Guo, Menglan Li, Zhenghui Wang, Hengliang Wang, Li Zhu, Chao Pan, Yufei Wang   +10 more
wiley   +1 more source

Mutated <i>DNMT3A</i> creates a public HLADQ- binding neoantigen on acute myeloid leukemia. [PDF]

Front Immunol
van der Lee DI, Argiro EM, Laan SNJ, Honders MW, de Jong RCM, Struckman NE, Falkenburg JHF, Griffioen M.   +7 more
europepmc   +1 more source

The transcription factor RIP140 regulates interferon γ signaling in breast cancer

International Journal of Cancer, EarlyView.
What's New? Interferon γ (IFNγ) is a key player in breast cancer, with the potential to induce apoptosis and to shift tumors into a dormant state. However, it also may promote carcinogenesis and angiogenesis. In this study, transcriptomic analysis identified the transcription factor RIP140 as a key regulator of IFNγ signaling in breast cancer.
Stéphan Jalaguier, Axel Kuehn, Chloé Petitpas, Arnaud Dulom, Rémy Jacquemont, Cindy Assi, Sophie Sixou, Udo Jeschke, Jacques Colinge, Vincent Cavaillès   +9 more
wiley   +1 more source

Bone marrow‐derived extracellular vesicles modulate the abundance of infiltrating immune cells in the brain and exert an antiviral effect against the Japanese encephalitis virus

FASEB BioAdvances, Volume 4, Issue 12, Page 798-815, December 2022., 2022
Abstract Mesenchymal stem cells (MSCs) have regenerative capacity and have reported a beneficial effect on the Japanese encephalitis virus (JEV) in an encephalitis model. However, the MSCs do not cross the blood–brain barrier and have other disadvantages limiting their therapeutic utility scope.
Naina Soni, Aarti Tripathi, Sriparna Mukherjee, Suchi Gupta, Sujata Mohanty, Anirban Basu, Arup Banerjee   +6 more
wiley   +1 more source